Park M J, Seo K N, Kang H J
Department of Orthopaedic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Korea.
J Bone Joint Surg Br. 2009 Nov;91(11):1482-6. doi: 10.1302/0301-620X.91B11.22519.
We evaluated 56 patients for neurological deficit after enucleation of a histopathologically confirmed schwannoma of the upper limb. Immediately after the operation, 41 patients (73.2%) had developed a new neurological deficit: ten of these had a major deficit such as severe motor or sensory loss, or intolerable neuropathic pain. The mean tumour size had been significantly larger in patients with a major neurological deficit than in those with a minor or no deficit. After a mean 25.4 months (12 to 85), 39 patients (70%) had no residual neurological deficit, and the other 17 (30%) had only hypoaesthesia, paraesthesiae or mild motor weakness. This study suggests that a schwannoma in the upper limb can be removed with an acceptable risk of injury to the nerve, although a transient neurological deficit occurs regularly after the operation. Biopsy is not advised. Patients should be informed pre-operatively about the possibility of damage to the nerve: meticulous dissection is required to minimise this.
我们对56例经组织病理学确诊的上肢神经鞘瘤摘除术后的患者进行了神经功能缺损评估。术后即刻,41例患者(73.2%)出现了新的神经功能缺损:其中10例有严重的功能缺损,如严重的运动或感觉丧失,或难以忍受的神经性疼痛。出现严重神经功能缺损的患者,其肿瘤平均大小显著大于出现轻微或无功能缺损的患者。平均25.4个月(12至85个月)后,39例患者(70%)无残留神经功能缺损,另外17例(30%)仅有感觉减退、感觉异常或轻度运动无力。本研究表明,上肢神经鞘瘤可以在可接受的神经损伤风险下切除,尽管术后经常会出现短暂的神经功能缺损。不建议进行活检。术前应告知患者神经损伤的可能性:需要细致解剖以尽量减少这种情况的发生。